Luis J. Schwarz

2.4k total citations · 1 hit paper
17 papers, 808 citations indexed

About

Luis J. Schwarz is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luis J. Schwarz has authored 17 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luis J. Schwarz's work include Cancer Genomics and Diagnostics (5 papers), Cancer Cells and Metastasis (3 papers) and HER2/EGFR in Cancer Research (3 papers). Luis J. Schwarz is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Cancer Cells and Metastasis (3 papers) and HER2/EGFR in Cancer Research (3 papers). Luis J. Schwarz collaborates with scholars based in Peru, United States and Chile. Luis J. Schwarz's co-authors include Carlos L. Arteaga, Justin M. Balko, Henry Gómez, Ángel Guerrero‐Zotano, Mónica V. Estrada, Melinda E. Sanders, Mellissa J. Nixon, Katherine E. Hutchinson, Kyung‐min Lee and Melissa M. Wolf and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and American Journal of Psychiatry.

In The Last Decade

Luis J. Schwarz

17 papers receiving 802 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

2017 479 citations Kyung‐min Lee, Jennifer M. Giltnane et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Luis J. Schwarz

Since Specialization

Citations

This map shows the geographic impact of Luis J. Schwarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis J. Schwarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis J. Schwarz more than expected).

Fields of papers citing papers by Luis J. Schwarz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis J. Schwarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis J. Schwarz. The network helps show where Luis J. Schwarz may publish in the future.

Co-authorship network of co-authors of Luis J. Schwarz

This figure shows the co-authorship network connecting the top 25 collaborators of Luis J. Schwarz. A scholar is included among the top collaborators of Luis J. Schwarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis J. Schwarz. Luis J. Schwarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Desorden linfoproliferativo germinotrópico asociado al HHV8/KSVH y EBV 2022 ·Luis J. Schwarz, (unknown), (unknown), Carlos Barrionuevo	1
2	Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors 2021 ·Frontiers in Oncology ·Jhajaira M. Araujo, (unknown), (unknown), Luis E. Raez, Christian Rolfo, Luis J. Schwarz, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Melanie Cornejo, (unknown), (unknown), (unknown), Joseph A. Pinto	9
3	Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer 2020 ·Clinical Breast Cancer ·Zaida Morante, Rossana Ruiz, Jhajaira M. Araujo, Joseph A. Pinto, Gabriel De la Cruz Ku, Diego Urrunaga‐Pastor, (unknown), Claudio Flores, (unknown), (unknown), Hugo Fuentes, Luis J. Schwarz, Alfredo Aguilar, Silvia P. Neciosup, Henry Gómez	17
4	Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America 2019 ·ecancermedicalscience ·Joseph A. Pinto, (unknown), Claudio Flores, Jhajaira M. Araujo, David Martı́nez, Luis J. Schwarz, (unknown), Leny Bravo, (unknown), (unknown), (unknown), Ricardo Fujita, Henry Gómez	8
5	Patterns of mutation enrichment in metastatic triple-negative breast cancer. 2019 ·Journal of Clinical Oncology ·(unknown), Claudio Flores, Luis J. Schwarz, Leny Bravo, (unknown), Jhajaira M. Araujo, Silvia P. Neciosup, Joseph A. Pinto	2
6	Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer 2019 ·Clinical Medicine Insights Oncology ·(unknown), Claudio Flores, Luis J. Schwarz, Leny Bravo, (unknown), Jhajaira M. Araujo, Silvia P. Neciosup, Joseph A. Pinto	20
7	Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial 2018 ·Clinical Cancer Research ·Dhivya R. Sudhan, Luis J. Schwarz, Ángel Guerrero‐Zotano, Luigi Formisano, Mellissa J. Nixon, Sarah Croessmann, Paula I. González-Ericsson, Melinda E. Sanders, Justin M. Balko, Francesca Avogadri-Connors, Richard E. Cutler, Alshad S. Lalani, Richard Bryce, Alan Auerbach, Carlos L. Arteaga	26
8	Helicobacter pylori: History and facts in Peru 2018 ·Critical Reviews in Oncology/Hematology ·(unknown), (unknown), (unknown), Alejandro Alfaro, Richard Ponce‐Cusi, Luis J. Schwarz, (unknown), (unknown), Joseph A. Pinto, Williams Fajardo	11
9	An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression 2017 ·JNCI Journal of the National Cancer Institute ·Luis J. Schwarz, Katherine E. Hutchinson, Brent N. Rexer, Mónica V. Estrada, Paula I. González-Ericsson, Melinda E. Sanders, Teresa C. Dugger, Luigi Formisano, Ángel Guerrero‐Zotano, Monica Red-Brewer, Christian D. Young, Johan Lantto, Mikkel W. Pedersen, Michael Kragh, Ivan D. Horak, Carlos L. Arteaga	35
10	MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation breakdown → 2017 ·Cell Metabolism ·Kyung‐min Lee, Jennifer M. Giltnane, Justin M. Balko, Luis J. Schwarz, Ángel Guerrero‐Zotano, Katherine E. Hutchinson, Mellissa J. Nixon, Mónica V. Estrada, Violeta Sánchez, Melinda E. Sanders, Taekyu Lee, Henry Gómez, Aňa Lluch, José Alejandro Pérez Fidalgo, Melissa M. Wolf, Gabriela Andrejeva, Jeffrey C. Rathmell, Stephen W. Fesik, Carlos L. Arteaga	479
11	Abstract 4818: Neratinib/fulvestrant but not fulvestrant alone maintain complete responses after treatment with trastuzumab/paclitaxel of mice bearing ER+/HER2+ xenografts 2017 ·Cancer Research ·Luis J. Schwarz, Sarah Croessmann, Francesca Avogadri-Connors, Richard E. Cutler, Alshad S. Lalani, Carlos L. Arteaga	3
12	Maybe we don't know JAK? 2016 ·Molecular & Cellular Oncology ·Luis J. Schwarz, Justin M. Balko	1
13	LYN-activating mutations mediate antiestrogen resistance in estrogen receptor–positive breast cancer 2014 ·Journal of Clinical Investigation ·Luis J. Schwarz, Emily M. Fox, Justin M. Balko, Joan T. Garrett, María G. Kuba, Mónica V. Estrada, Ana M. González-Angulo, Gordon B. Mills, Monica Red-Brewer, Ingrid A. Mayer, Vandana G. Abramson, Monica Rizzo, Mark C. Kelley, Ingrid M. Meszoely, Carlos L. Arteaga	31
14	Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer 2013 ·Cancer Research ·Justin M. Balko, Luis J. Schwarz, Neil E. Bhola, Richard Kurupi, Philip Owens, Todd W. Miller, Henry Gómez, Rebecca S. Cook, Carlos L. Arteaga	122
15	Colombia - Report on the Observance of Standards and Codes (ROSC) : accounting and auditing 2003 ·(unknown), Luis J. Schwarz	5
16	Salivary output of the alcoholic: Effect of treatment with amitriptyline 1968 ·PubMed ·John A. Stern, Luis J. Schwarz, (unknown)	3
17	Blood Sugar Levels in Patients Treated with Chlorpromazine 1968 ·American Journal of Psychiatry ·Luis J. Schwarz, Rodrigo Muñoz	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact